Mass Spectrometry Imaging in Oncology Drug Discovery

Area of Science:

• Oncology
• Pharmacology
• Analytical Chemistry

Background:

• Mass spectrometry imaging (MSI) has become integral to modern drug discovery and development.
• Its application in oncology is particularly impactful for evaluating drug performance within the complex tumor microenvironment.

Purpose of the Study:

• To discuss the diverse roles of MSI in drug discovery and development.
• To highlight specific applications of MSI in oncology research, including tumor metabolism.
• To address the challenges and advancements in applying MSI in industrial research.

Main Methods:

• Review of MSI applications in drug discovery.
• Discussion of MSI for biodistribution and pharmacokinetic-pharmacodynamic (PK-PD) analyses.
• Exploration of MSI for tumor microenvironment and metabolism studies.

Main Results:

• MSI enables assessment of compound efficacy and safety in oncology.
• MSI facilitates understanding of compound and metabolite biodistribution.
• MSI aids in defining PK-PD relationships applicable across drug discovery projects.

Conclusions:

• MSI is a powerful tool for oncology drug discovery, offering insights into efficacy, safety, and tumor metabolism.
• The technology supports biodistribution and PK-PD analyses crucial for all drug development.
• Advancements in metrology are enhancing the application of MSI in industry research.